SEC Filings for CollPlant Biotechnologies Ltd. (CLGN)

$ 10.035   0.065 (+0.65%) Volume: 6.28k 1:29 PM EDT 2-Jul-2020
Filing Type:
Form TypeForm DescriptionPagesDateView
424B3Prospectus [Rule 424(b)(3)]3606/05/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341305/27/2020
F-3Registration statement for securities of certain foreign private issuers4605/27/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934305/14/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19344704/07/2020
20-FRegistration statement / Annual report / Transition report30504/01/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 19341404/01/2020
DNotice of Exempt Offering of Securities103/09/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934303/06/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934502/14/2020
SC 13G/A[Amend] Statement of acquisition of beneficial ownership by individuals302/12/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934502/10/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934502/04/2020
6-KReport of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934401/13/2020
<<
First
<
Prev
123456789